Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 169,500 UNCY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 169,500 | n/a |
| Jul 30, 2025 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 90,000 | n/a |
| Aug 14, 2024 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 81,750 | n/a |
| Apr 17, 2024 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 463,250 | n/a |
| Aug 30, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 1,355,000 | n/a |
| Jul 13, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Exercise/Conversion | 41,845 | n/a |
| Mar 10, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 20 | $20.0K |
| Nov 23, 2022 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 28,000 | n/a |
| Jul 26, 2021 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 34,884 | n/a |